227 related articles for article (PubMed ID: 22815685)
1. β1 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to β-blocker therapy and prognosis.
Liu WN; Fu KL; Gao HY; Shang YY; Wang ZH; Jiang GH; Zhang Y; Zhang W; Zhong M
PLoS One; 2012; 7(7):e37659. PubMed ID: 22815685
[TBL] [Abstract][Full Text] [Related]
2. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
[TBL] [Abstract][Full Text] [Related]
3. β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.
Pereira SB; Velloso MW; Chermont S; Quintão MM; Nunes Abdhala R; Giro C; Oliveira E Alves T; Camacho V; De Fátima Maia Contarato L; Pena FM; Balieiro HM; Garcia ML; Da Nóbrega AC; Ribeiro GS; Mesquita ET
Mol Med Rep; 2013 Jan; 7(1):259-65. PubMed ID: 23064657
[TBL] [Abstract][Full Text] [Related]
4. β1-Adrenergic receptor Arg389Gly polymorphism affects the antiarrhythmic efficacy of flecainide in patients with coadministration of β-blockers.
Doki K; Sekiguchi Y; Kuga K; Aonuma K; Homma M
Pharmacogenet Genomics; 2016 Oct; 26(10):481-5. PubMed ID: 27500822
[TBL] [Abstract][Full Text] [Related]
5. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure].
Yu WP; Lou M; Deng B; Song HM; Wang HB
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):776-80. PubMed ID: 17217681
[TBL] [Abstract][Full Text] [Related]
6. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.
Terra SG; Hamilton KK; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hill JA; Aranda JM; Yarandi HN; Johnson JA
Pharmacogenet Genomics; 2005 Apr; 15(4):227-34. PubMed ID: 15864115
[TBL] [Abstract][Full Text] [Related]
7. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
Schwartz SG; Puckett BJ; Allen RC; Castillo IG; Leffler CT
Ophthalmology; 2005 Dec; 112(12):2131-6. PubMed ID: 16325708
[TBL] [Abstract][Full Text] [Related]
8. Myocardial beta1-adrenergic receptor polymorphisms affect functional recovery after ischemic injury.
Akhter SA; D'Souza KM; Petrashevskaya NN; Mialet-Perez J; Liggett SB
Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1427-32. PubMed ID: 16537791
[TBL] [Abstract][Full Text] [Related]
9. Association of the beta-1 adrenergic receptor carboxyl terminal variants with left ventricular hypertrophy among diabetic and non-diabetic survivors of acute myocardial infarction.
Hakalahti AE; Tapanainen JM; Junttila JM; Kaikkonen KS; Huikuri HV; Petäjä-Repo UE
Cardiovasc Diabetol; 2010 Aug; 9():42. PubMed ID: 20731869
[TBL] [Abstract][Full Text] [Related]
10. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
Liu J; Liu ZQ; Tan ZR; Chen XP; Wang LS; Zhou G; Zhou HH
Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
[TBL] [Abstract][Full Text] [Related]
11. [Interactions between beta1 and beta2 adrenergic receptor polymorphisms as risk factors for chronic heart failure].
Moraga F; Troncoso R; Mellado R; Díaz-Araya G; Vukasovic JL; Greig D; Perez O; García L; Roldán J; Ocaranza MP; Jali J; Chiong M; Castro P
Rev Med Chil; 2008 Nov; 136(11):1371-80. PubMed ID: 19301767
[TBL] [Abstract][Full Text] [Related]
12. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
[TBL] [Abstract][Full Text] [Related]
13. Markedly reduced effects of (-)-isoprenaline but not of (-)-CGP12177 and unchanged affinity of beta-blockers at Gly389-beta1-adrenoceptors compared to Arg389-beta1-adrenoceptors.
Joseph SS; Lynham JA; Grace AA; Colledge WH; Kaumann AJ
Br J Pharmacol; 2004 May; 142(1):51-6. PubMed ID: 15037517
[TBL] [Abstract][Full Text] [Related]
14. Association of beta-adrenoceptor polymorphisms with cardiac autonomic modulation in Japanese males.
Matsunaga T; Yasuda K; Adachi T; Gu N; Yamamura T; Moritani T; Tsujimoto G; Tsuda K
Am Heart J; 2007 Oct; 154(4):759-66. PubMed ID: 17893006
[TBL] [Abstract][Full Text] [Related]
15. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
[TBL] [Abstract][Full Text] [Related]
16. Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction.
Yilmaz A; Kaya MG; Merdanoglu U; Ergun MA; Cengel A; Menevse S
J Clin Lab Anal; 2009; 23(4):237-43. PubMed ID: 19623647
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms.
O'Connor CM; Fiuzat M; Carson PE; Anand IS; Plehn JF; Gottlieb SS; Silver MA; Lindenfeld J; Miller AB; White M; Walsh R; Nelson P; Medway A; Davis G; Robertson AD; Port JD; Carr J; Murphy GA; Lazzeroni LC; Abraham WT; Liggett SB; Bristow MR
PLoS One; 2012; 7(10):e44324. PubMed ID: 23071495
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism in the beta(1)-adrenergic receptor gene and hypertension.
Bengtsson K; Melander O; Orho-Melander M; Lindblad U; Ranstam J; Råstam L; Groop L
Circulation; 2001 Jul; 104(2):187-90. PubMed ID: 11447084
[TBL] [Abstract][Full Text] [Related]
19. Suppressive effect of the Gly389 allele of the beta1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy.
Iwai C; Akita H; Shiga N; Takai E; Miyamoto Y; Shimizu M; Kawai H; Takarada A; Kajiya T; Yokoyama M
Circ J; 2002 Aug; 66(8):723-8. PubMed ID: 12197595
[TBL] [Abstract][Full Text] [Related]
20. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
